KIC Ventures Group and over 10 other investment firms, key expert surgeon leaders and engineers have invested their time, expertise and over $85 million since 2001 to bring AxioMed technology to patients. When you talk to these individuals about why they've invested so much into this technology, they all credit the disc performing like a true disc replacement, which far exceeds any other design.

​

According to CFO Aditya Humad, AxioMed raised capital from physicians, family offices and other high net worth individuals in its prior rounds and has a current round open to begin manufacturing and commercialize the disc next year.

​

Because of its viscoelastic core, the AxioMed disc is designed for safe MRI compatibility.

​

Leading surgeons note that the AxioMed disc compresses during flexion while ball and socket discs show no motion and thus act like a fusion device. They also note that there is substantial scar tissue formation around the ball and socket space that restricts motion during revisions. AxioMed has a 15 year head start in understanding viscoelastic disc replacement and this lead will increase with greater clinical utilization globally. AxioMed has designed and completed preliminary testing for its Lateral Lumbar Disc that will follow next, after it receives US FDA Approval on its Anterior Lumbar Disc.

​

Implanting the lumbar disc laterally will be a game changer.